Choosing the best first line oral drug agent in patients with pulmonary hypertension: evidence from a network meta-analysis

Int J Cardiol. 2013 Oct 9;168(4):4336-8. doi: 10.1016/j.ijcard.2013.05.084. Epub 2013 Jun 10.

Authors

Giuseppe Biondi-Zoccai¹, Fabrizio D'Ascenzo, Margherita Cannillo, Nicky J Welton, Walter Grosso Marra, Pierluigi Omedè, Daniela Libertucci, Enrico Fusaro, Michele Capriolo, Jacopo Perversi, Francesco Fedele, Giacomo Frati, Massimo Mancone, James J Dinicolantonio, Carmine Dario Vizza, Claudio Moretti, Fiorenzo Gaita

Affiliation

¹ Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Italy; Meta-analysis and Evidence based medicine Training in Cardiology (METCARDIO), Italy.

PMID: 23755974
DOI: 10.1016/j.ijcard.2013.05.084

No abstract available

Keywords: Clinical end point; Oral therapy; Pulmonary arterial hypertension.

Publication types

Letter
Meta-Analysis

MeSH terms

Administration, Oral
Antihypertensive Agents / administration & dosage*
Humans
Hypertension, Pulmonary / drug therapy*

Substances

Antihypertensive Agents

Grants and funding